{
    "organizations": [],
    "uuid": "e94962323bf692eccc603f8f3219c346af7a9b7f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-proteomics-international-laborator/brief-proteomics-international-laboratories-updates-on-investment-in-cpr-pharma-services-idUSFWN1PR1BU",
    "ord_in_thread": 0,
    "title": "BRIEF-Proteomics International Laboratories Updates On Investment In CPR Pharma Services",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 2 (Reuters) - Proteomics International Laboratories Ltd :\n* ASX ALERT-STRATEGIC ALLIANCE AND INVESTMENT IN CPR PHARMA SERVICES-PIQ.AX\n* ‍ OFFER TO ACQUIRE 10% OF CPR PHARMA SERVICES THROUGH ISSUE OF 4 MILLION CO SHARES ​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-02T06:36:00.000+02:00",
    "crawled": "2018-02-02T13:01:26.031+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "proteomics",
        "international",
        "laboratory",
        "ltd",
        "asx",
        "alliance",
        "investment",
        "cpr",
        "pharma",
        "offer",
        "acquire",
        "cpr",
        "pharma",
        "service",
        "issue",
        "million",
        "co",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}